J1611 Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg

Short descriptor: Inj glucagon hcl, fresenius

✓ Active HCPCS Level II 2026
Open J1611 in the app →

Look up J1611 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J1611 is the HCPCS Level II code for Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2023-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
glucagon hydrochloride, not therapeutically equivalent to j1610
Dose / Unit
per 1 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J1611 with the canonical source and edition:

J1611 — Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J1611

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J1611

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial